PRODUCT DETAILS

About Eglucent Rapid 100IU/ml Kwikpen

INSULIN LISPRO contains human insulin used to treat type 1 and type 2 diabetes mellitus. Diabetes mellitus is a condition that affects how the body processes glucose. In Diabetes Mellitus Type 1, the body does not produce enough insulin to regulate blood sugar levels. On the other hand, in Diabetes Mellitus type 2, either the body stops producing enough insulin (a hormone that helps lower blood sugar levels), or there is resistance to insulin action.

Uses of Eglucent Rapid 100IU/ml Kwikpen

Type 1 diabetes mellitus, Type 2 diabetes mellitus

Medicinal Benefits of Eglucent Rapid 100IU/ml Kwikpen

INSULIN LISPRO works by ensuring rapid and consistent sugar control. It facilitates the reuptake of sugar in muscle and fat cells and thus, suppresses the production of sugar in the liver. It helps to decrease blood sugar levels after the intake of meals. It prevents the chances of developing serious complications of diabetes. Besides this, INSULIN LISPRO can be safely prescribed during the pregnancy as well as lactation stage. INSULIN LISPRO helps in improving the glycaemic control which in turn decreases the risk of progression of complications of diabetes like damage of retina (retinopathy), damage of kidney (nephropathy), damage of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer and others.

Directions for Use

INSULIN LISPRO should be administered subcutaneously in the abdomen or thigh region. If you are not well trained to self-administer INSULIN LISPRO, ask a healthcare professional to administer it. INSULIN LISPRO should never be administered intravenously or in the vein.

Side Effects of Eglucent Rapid 100IU/ml Kwikpen

• Hypoglycemia (low blood glucose levels)
• Injection site reactions (redness, swelling)

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

INSULIN LISPRO is for subcutaneous use only and should never be administered intravenously (IV) or in the veins. Cases of heart failure have been reported when pioglitazone was used with insulin, especially in patients who are at high risk of cardiac heart failure. The first symptoms of hyperglycaemia (high blood sugar level) may include symptoms like excessive thirst, dry mouth, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, loss of appetite and acetone odour of the breath. You should closely monitor these symptoms. Symptoms like heart failure, weight gain and oedema (fluid deposition in tissue) should not be overruled. It is advisable not to consume alcohol as it may either increase or decrease your blood glucose level. Care should be taken while travelling across more than two time zones. Your doctor may adjust your insulin schedule. INSULIN LISPRO may decrease the level of potassium, leading to a state of hypokalaemia that, if left untreated, may lead to respiratory paralysis, irregular heartbeat rhythm, coma and even death. Do not take INSULIN LISPRO if you have any low blood glucose levels, kidney, liver, or heart problems.

Drug Interactions

Drug-Drug Interaction:

INSULIN LISPRO may have an interaction with anti-depressants (phenelzine, iproniazid, isocarboxazid, nialamide, imipramine, desipramine, tranylcypromine, moclobemide), anti-Parkinson’s drug (selegiline), antibiotic (linezolid), (lithium, tryptophan), migraines drug (sumatriptan), pain killer (tramadol), anti-ulcer (cimetidine, lansoprazole, omeprazole), anti-fungal (fluconazole), anti-stroke pills (ticlopidine), blood-thinners (warfarin, dipyridamole, and phenprocoumon), antimalarial (mefloquine), heart-related drug (flecainide, propafenone), and medicines that decrease blood levels of potassium or magnesium, as these increase the risk of life-threatening heart rhythm disorder. Besides this, the use of oral antidiabetic pills like pramlintide acetate and antibiotics (pentamidine) may cause hypoglycaemia (low blood sugar level).

Drug-Disease Interaction:

 INSULIN LISPRO should not be given to patients with kidney disease, liver disease, low potassium level (hypokalaemia), and low blood sugar/glucose level (hypoglycaemia)

Safety Advice

ALCOHOL

You are recommended not to consume alcohol along with INSULIN LISPRO to avoid unpleasant side-effects. Alcohol may either decrease or increase the blood sugar level which can be fatal.

PREGNANCY

Please inform your doctor if you are pregnant as a dose adjustment may be required. The amount of insulin you need usually falls during the first three months of pregnancy and increases for the remaining six months. If you are breast-feeding, you may need to alter your insulin intake or diet.

BREAST FEEDING

Please inform your doctor if you are breastfeeding as a dose adjustment may be required

DRIVING

Drive with caution, INSULIN LISPRO usually causes drowsiness and affects driving ability. Your ability to concentrate and react may be reduced if you have hypoglycaemia (low blood sugar).

LIVER

INSULIN LISPRO to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.

KIDNEY

INSULIN LISPRO to be taken with caution, especially if you have a history of kidney diseases/conditions. The dose may have to be adjusted by your doctor.